Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Eugeniusz K Machaj"'
Autor:
Jerzy Kawiak, Zbigniew Polanski, Wladyslawa Streminska, Agnieszka Gawrysiak, Zygmunt Pojda, Eugeniusz K Machaj, Jerzy Moraczewski, Grazyna Hoser, Edyta Brzoska, Maria A. Ciemerych, Iwona Grabowska
Publikováno v:
Cell Transplantation, Vol 21 (2012)
Nonhematopoietic cord blood cells and mesenchymal cells of umbilical cord Wharton's jelly have been shown to be able to differentiate into various cell types. Thus, as they are readily available and do not raise any ethical issues, these cells are co
Autor:
Krystyna Domanska-Janik, Leonora Buzanska, Zygmunt Pojda, Eugeniusz K Machaj, Barbara Zabłocka
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Neural stem cells are clonogenic, self-renewing cells with the potential to differentiate into brain-specific cell lines. Our study demonstrates that a neural-stem-cell-like subpopulation can be selected and expanded in vitro by the use of human umbi
Autor:
Jakub Golab, M Wasik, Eugeniusz K Machaj, Grzegorz M. Wilczynski, Anna Czajka, Adam Giermasz, Marek Jakóbisiak, Jolanta Rybczynska, Rafal Kaminski, Katarzyna Kozar, Wojciech Feleszko, Tomasz Oldak, Tomasz Stoklosa, Radoslaw Zagozdzon, Witold Lasek, Anna Dabrowska
Publikováno v:
British Journal of Cancer
Europe PubMed Central
Europe PubMed Central
Photofrin®-based photodynamic therapy (PDT) has recently been approved for palliative and curative purposes in cancer patients. It has been demonstrated that neutrophils are indispensable for its anti-tumour effectiveness. We decided to evaluate the
Autor:
Wojciech Feleszko, A. Kaca, Zygmunt Pojda, Adam Giermasz, Anna Dabrowska, Marek Jakóbisiak, A. Iwan-Osiecka, Witold Lasek, Tomasz Stoklosa, Eugeniusz K Machaj, Radoslaw Zagozdzon, Jakub Golab
Publikováno v:
Annals of Oncology. 9:63-69
Summary Background IL-12 has been successfully used in experimental tumor therapy. However, administration of this cytokine induces dose-dependent suppression of hematopoiesis that could potentially limit its use in clinical trials. We decided to exa
Autor:
Zygmunt Pojda, A Sobiczewska, A Wrembel, Grazyna Hoser, Eugeniusz K Machaj, Jerzy Kawiak, B Miks
Publikováno v:
Immunology and Cell Biology. 74:163-166
The influence of granulocyle-colony stimulating factor (G-CSF) on thymocyte subsets and peripheral blood leucocytes in leukaemia L1210-bearing mice was evaluated. Leukaemia-bearing mice have a markedly reduced L3T4+Lyt2+ thymocyte subpopulation. We o
Autor:
Wladyslawa Streminska, Katarzyna Jańczyk-Ilach, Jerzy Kawiak, Maria A. Ciemerych, Eugeniusz K Machaj, Iwona Grabowska, Edyta Brzoska, Grazyna Hoser, Zygmunt Pojda, Jerzy Moraczewski
Publikováno v:
Current stem cell researchtherapy. 8(1)
Different sources of stem cells are considered as a potential source of precursor cells that could improve skeletal muscle regeneration. Under physiological conditions muscle regeneration is based on the satellite cells, i.e. adult muscle precursor c
Autor:
Małgorzata, Zawadzka, Katarzyna, Lukasiuk, Eugeniusz K, Machaj, Zygmunt, Pojda, Bozena, Kamińska
Publikováno v:
Acta neurobiologiae experimentalis. 69(1)
The finding of stem/progenitor cells in postnatal bone marrow and umbilical cord blood, opens up a possibility of using stem cells to treat neurologic diseases. There is a controversy, whether intravenously administered human umbilical cord blood cel
Autor:
Edyta Brzoska, Wladyslawa Streminska, Grazyna Hoser, Eugeniusz K Machaj, Zygmunt Pojda, Jerzy Moraczewski, Jerzy Kawiak, Iwona Grabowska, Danuta Wasilewska
Publikováno v:
Experimental hematology. 34(9)
Objective In this report, we demonstrate the participation of human cord blood (HUCB) stem cells in the skeletal muscle regeneration of SCID (severe combined immunodeficient) mice. Materials and Methods The HUCB cells were labeled with the PKH26 fluo
Autor:
Jerzy Kawiak, Tomasz Skirecki, Jarosław Czubak, Grazyna Hoser, Danuta Wasilewska, Zygmunt Pojda, Eugeniusz K Machaj
Publikováno v:
Stem Cell Research & Therapy
Introduction An effective immune response to severe bacterial infections requires a robust production of the innate immunity cells from hematopoietic stem and progenitor cells (HSPCs) in a process called emergency myelopoiesis. In sepsis, an altered